Provention Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Provention Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2022.
  • Provention Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $321K, a 13.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $321K -$52K -13.9% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $336K -$48K -12.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $350K -$43K -10.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $362K -$39K -9.73% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $373K -$35K -8.58% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $384K Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $393K Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $401K Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $408K Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.